Mohamad Isam Saeed

TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease

J. Jensen, C. Ulrik, P. Sivapalan, 2020, Trials.

Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms

J. Vestbo, N. Seersholm, N. Jørgensen, 2022, PloS one.

Use of Inhaled Corticosteroids and Risk of Acquiring Haemophilus influenzae in Patients with Chronic Obstructive Pulmonary Disease

R. Dessau, S. Nielsen, P. Sivapalan, 2022, Journal of clinical medicine.

The Impact of Social Distancing in 2020 on Admission Rates for Exacerbations in Asthma: A Nationwide Cohort Study

T. Biering-Sørensen, C. Ulrik, P. Sivapalan, 2022, The journal of allergy and clinical immunology. In practice.

Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients

T. Biering-Sørensen, N. Seersholm, F. Knop, 2021, Biomedicines.

Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-

N. Seersholm, C. Ulrik, F. Rosenvinge, 2022, Trials.

Polymorphisms of the Glucocorticoid Receptor Gene and Adrenal Suppression in Patients with Chronic Obstructive Pulmonary Disease Treated with Glucocorticoids for Acute Exacerbations

J. Vestbo, N. Seersholm, N. Jørgensen, 2020 .